Life sciences connect

A curated hub for industry professionals across biotech, pharmaceuticals, medtech, diagnostics, AI and clinical research - designed to inform, connect, and inspire.

If you're a decision-maker in the life sciences sector - whether you're a biotech founder, medtech innovator, investor, research leader, or industry advisor - life sciences connect is designed for you.

Our specialist practice spans the full spectrum of life sciences, including:

Biotechnology and pharmaceuticals: From early-stage discovery to clinical translation and commercialisation.
Medical technology and diagnostics: Wearable technologies, imaging, and point-of-care innovation.
Digital health and AI: Tools driving smarter research, personalised medicine, and remote monitoring.
Academic and CRO collaboration: Helping bridge science and strategy across partnerships.
Advanced therapies and IP strategy: Gene therapy, biologics, and next-gen intellectual property protection.

Life sciences

Life sciences connect benefits

Built on our deep expertise in supporting life science clients, life sciences connect brings innovators together to spark ideas, drive growth, and shape change. As a member, you’ll gain:

About

Browne Jacobson barrister and solicitor appointed as Deputy District Judges

About

Our people

Browne Jacobson announces Jonathan Tardif as next Senior Partner

Our people

Sectors

Browne Jacobson chooses Legora for firm-wide AI deployment

Sectors

Services

Services

Insights

Wales Week 2026: Scaling corporate success in Wales

Insights

Careers

Browne Jacobson takes number one spot in social mobility Index – and top law firm for fifth consecutive year

Careers

International

Browne Jacobson IP team ranked among the world’s leading trademark advisers

International

Locations

Browne Jacobson moves into new Cardiff office at One Central Square

Locations

Life sciences connect

Life sciences connect benefits

Join life science connect

Key contact

Gerard Hanratty

Partner

Related expertise

You might be interested in

AI liability in healthcare: Important updates from the UK jurisdiction taskforce

Belief, context and causation: Lessons from Omooba

EU AI Act application for high-risk AI medical devices delayed: Legal comment

Employment Rights Act 2025: Are you ready for the April 2026 changes?

Browne Jacobson and CBI to launch report on future of PPPs in financing infrastructure at UKREiiF

EMA and FDA guiding principles for AI in drug development: A review

Browne Jacobson advises shareholders on £15m BGF investment into Seda Pharma Development Services

Life sciences in Wales: Why 2026 could be a breakthrough year

Spring Statement 2026: Comments from Browne Jacobson lawyers

Shared Insights: Avoiding pitfalls when implementing AI in the health and care sector

UK Supreme Court aligns patentability test with EPO in Emotional Perception case

MHRA consultation on indefinite recognition of CE-marked medical devices: Legal comment

Promoting commercial thinking within the NHS

Maximising commercial revenue for the NHS: Post-event summary

National Cancer Plan: Legal comment

Damned if they do, damned if they don’t: Understanding and mitigating the risk of AI tools in healthcare practice

Browne Jacobson moves into new Cardiff office at One Central Square

The UK as a global life sciences hub: Legal infrastructure and innovation policy

Court transparency pilot: New public access rules from 1 January 2026

Employment Rights Act 2025 is passed as Bill receives royal assent: Legal comment

Employment Rights Act: Finally here

Breaking the chains: The future of non-compete clauses

The Employment Rights Bill: Almost here?

The Employment Rights Bill: An overview for employers

Browne Jacobson corporate health partner recognised as ‘one to watch’ at national industry awards

The Employment Rights Bill: Government drops ‘day one’ unfair dismissal rights

Current life sciences insurance trends and the imperative for specialised coverage

Browne Jacobson responds to the Autumn Budget 2025

Confidentiality in clinical trials: Arbitration as the preferred route for dispute resolution

Autumn Budget 2025 predictions: Conclusion

2025 Autumn Budget predictions

The Employment Rights Bill: Still not here yet

Cross-border collaboration in Life Sciences: How to make it work

Browne Jacobson contributes to white paper exploring UK-UAE collaboration in healthcare AI adoption

How MHRA’s international reliance is shaping UK medicine regulation

Technology-enabled care in the UK: Legal and technical developments to watch

The importance of AI in the development life sciences

Arbitrating innovation: Resolving IP disputes in the life sciences sector

Browne Jacobson comments on Irish Budget

When does sexual harassment by an employee take place in the course of employment?